Archive for Profitability
Announcing a new partnership with e-CASS
We are pleased to announce that Dispex is now working in collaboration with e-CASS to ensure our Dispex members enhance the already great advantages of using e-CASS as your single...
AstraZeneca – Forxiga – Clarification
From pack 1 each month there will be 30% discount, which works out as costing £25.61 for the first 20 and there will be 40% discount thereafter, which works out...
Keeping Your Dispensary Informed:
Brand Comparisons, Profitability Insights & Top Tips from Dispex Are you staying ahead of the changes? At Dispex, we continually monitor changes within the dispensing world, updating our brand comparison...
Diabetes – Glucagon-like Peptide-1 receptor Agonists (GLP1)
By Dispex More and more patients are being started on GLP1 agonists in an attempt to bring their diabetes and weight under control. There are 7 injectable brands, as well...
Manufacturers Rebate Scheme Changes
By Dr Philip Koopowitz – Director Dispex MDS, RWA, QE and now ePACT Over the past month we have seen 2 manufacturers move the way they deal with rebates away...
Brand Comparisons Update
By Dispex All Brand Comparisons have been updated in the last couple of weeks and now show the difference in profitability when prescribed generically and a brand is dispensed, where...
Pop-up Reminders – The Dispex Nudger
By Dr Philip Koopowitz – Director Dispex
Inclisiran – a further update and clarification
By Dr Philip Koopowitz – Director Dispex The reimbursement price of Inclisiran is £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment...
We Value Your Input-formularies
By Dispex As we added more formularies, we heard your feedback that the webpage was becoming harder to navigate. We’ve taken that on board and are pleased to announce that...
Brand comparisons on Lixiana
Check Dispex website Brand comparisons to see profit on Lixiana . MUST be ordered from Alliance to get the discount. https://dispex.net/profitability-tools/brand-comparisons/cvs-noacs/ Patent set to expire 21st August 2028
Colecalciferol – Bringing Sunshine to your patients – Part 3
By Dr Philip Koopowitz – Director Dispex Making sense of Vitamin D prescribing for Treatment of vitamin D deficiency (Loading dose) Many dispensaries have a range of dosages, forms (capsules,...
Hayfever Formulary for 2025
By Dr Philip Koopowitz – Director Dispex The Hayfever season is well and truly upon us. This month we look at the current common treatments’ available for runny noses, sneezing...
